top of page
Executive Spotlights

Hummingbird and Synaffix agree to antibody-drug conjugate deal worth up to $150M

Singapore & Oss, Netherlands, January 4. 2023 (Endpoints News) -- The Dutch biotech Synaffix has been active on the deal front for the past few years. And it’s not showing signs of stopping, hitting the ground running in 2023 by inking a deal with Singapore’s Hummingbird Bioscience.

Read full article here.

Recent Posts

See All

R3 Vascular Raises $87M in Series B Financing

Mountain View, CA, May 20, 2024 (FinSMEs) -- R3 Vascular, a medical device firm headquartered in California, secured $87 million in Series B financing. The funding round, spearheaded by Deerfield Ma


Life Science Headlines
bottom of page